Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 146 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1451 8.0 months Stage IV melanoma 4 Chemotherapy
The Angeles Clinic and Research Institute United States 7/2011
Treatment Details: Patients: This phase II study involved stage IV melanoma patients who were divided into three separate treatment groups. Group A consisted of 32 patients with a median age of 64 years; 56%
 
1452 8.0 months Advanced hepatocellular carcinoma 4 Chemotherapy
Ain Shams University Egypt 7/2012
Treatment Details: Patients: This study involved 40 advanced hepatocellular carcinoma patients with no prior chemotherapy. The median age was 55 years and 92.5% were male. Treatment: Patients were treate
 
1453 8.0 months Advanced bladder cancer 5 Chemotherapy
Heinrich-Heine-University Germany 2/2011
Treatment Details: Patients: This phase 3 study involved 4 advanced bladder cancer patients who had previously received cisplatin-based chemotherapy. The median patient age was 65.1 years; no information abo
 
1454 8.0 months Advanced hepatocellular carcinoma 5 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 2/2014
Treatment Details: Patients: This phase 2 study involved 24 advanced hepatocellular carcinoma patients. The median patient age was 67.5 years and 83% were male. Treatment: Patients received biologic ther
 
1455 8.0 months Metastatic urothelial carcinoma 3 Biologic therapy
Fondazione IRCCS Istituto Nazionale dei Tumori Italy 2/2014
Treatment Details: Patients: This phase 2 study involved 14 pre-treated metastatic urothelial cancer patients. The median patient age was 64 years and 13 were male. Treatment: Patients were treated with
 
1456 8.0 months Liver Cancer 4 Chemotherapy
University of Bologna Italy 6/2015
Treatment Details: Patients: This study involved 26 hepatocellular carcinoma patients who had been previously treated with sorafenib. The median patient age was 66 years and 88.4% were male. Treatment: P
 
1457 8.0 months NHL 5 Biologic therapy
University of Rochester United States 7/2015
Treatment Details: Patients: This phase 2 study involved 37 peripheral T Cell lymphoma patients who had been previously treated. The median patient age was 62 years and 65% were male. Treatment: Patients
 
1458 7.9 months Metastatic colon cancer 4 Chemotherapy
Cookridge Hospital United Kingdom 3/2003
Treatment Details: Patients: This Phase I study involved 37 patients with metastatic colon cancer whose cancer had grown or returned (progressed) after being treated with the chemotherapy drug 5-FU. Treatme
 
1459 7.9 months Recurrent GBM 4 Chemotherapy
University of California at San Francisco United States 1/2004
Treatment Details: Patients: This Phase II study involved 36 adult patients with recurrent glioblastoma multiforme and 2 patients with gliosarcoma. Treatment: Treatment consisted of two chemotherapy drugs
 
1460 7.9 months Advanced NSCLC 4 Chemotherapy
Georgetown University Medical Center United States 10/2002
Treatment Details: Patients: This Phase II study involved 32 patients with advanced (stage IIIB or IV or recurrent) non-small-cell lung cancer. None of the patients had received prior chemotherapy. Treatm
 
Page 146 of 187  | Previous Page  | Next Page